View in EDS PDF Full Text

Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.

Saved in:
Bibliographic Details
Title: Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.
Authors: Gerlza T; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria., Winkler S; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria., Atlic A; VTU Technology, Parkring 18, A-8074 Grambach/Graz, Austria., Zankl C; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria., Konya V; Medizinische Universität Graz, Institute of Experimental and Clinical Pharmacology, Universitätsplatz 4, A-8010 Graz, Austria., Kitic N; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria., Strutzmann E; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria., Knebl K; ProtAffin Biotechnologie AG, Reininghausstrasse 13a, A-8020 Graz, Austria., Adage T; ProtAffin Biotechnologie AG, Reininghausstrasse 13a, A-8020 Graz, Austria., Heinemann A; Medizinische Universität Graz, Institute of Experimental and Clinical Pharmacology, Universitätsplatz 4, A-8010 Graz, Austria., Weis R; VTU Technology, Parkring 18, A-8074 Grambach/Graz, Austria., Kungl AJ; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria ProtAffin Biotechnologie AG, Reininghausstrasse 13a, A-8020 Graz, Austria Antagonis Biotherapeutics, Strasserhofweg 77a, A-8045 Graz, Austria andreas.kungl@uni-graz.at.
Source: Protein engineering, design & selection : PEDS [Protein Eng Des Sel] 2015 Aug; Vol. 28 (8), pp. 231-40. Date of Electronic Publication: 2015 May 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101186484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1741-0134 (Electronic) Linking ISSN: 17410126 NLM ISO Abbreviation: Protein Eng Des Sel Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25969511
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gerlza+T%22">Gerlza T</searchLink>; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Winkler+S%22">Winkler S</searchLink>; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Atlic+A%22">Atlic A</searchLink>; VTU Technology, Parkring 18, A-8074 Grambach/Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Zankl+C%22">Zankl C</searchLink>; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Konya+V%22">Konya V</searchLink>; Medizinische Universität Graz, Institute of Experimental and Clinical Pharmacology, Universitätsplatz 4, A-8010 Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Kitic+N%22">Kitic N</searchLink>; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Strutzmann+E%22">Strutzmann E</searchLink>; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Knebl+K%22">Knebl K</searchLink>; ProtAffin Biotechnologie AG, Reininghausstrasse 13a, A-8020 Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Adage+T%22">Adage T</searchLink>; ProtAffin Biotechnologie AG, Reininghausstrasse 13a, A-8020 Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Heinemann+A%22">Heinemann A</searchLink>; Medizinische Universität Graz, Institute of Experimental and Clinical Pharmacology, Universitätsplatz 4, A-8010 Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Weis+R%22">Weis R</searchLink>; VTU Technology, Parkring 18, A-8074 Grambach/Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Kungl+AJ%22">Kungl AJ</searchLink>; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Universitätsplatz 1, A-8010 Graz, Austria ProtAffin Biotechnologie AG, Reininghausstrasse 13a, A-8020 Graz, Austria Antagonis Biotherapeutics, Strasserhofweg 77a, A-8045 Graz, Austria andreas.kungl@uni-graz.at.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101186484%22">Protein engineering, design & selection : PEDS</searchLink> [Protein Eng Des Sel] 2015 Aug; Vol. 28 (8), pp. 231-40. <i>Date of Electronic Publication: </i>2015 May 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101186484 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1741-0134 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217410126%22">17410126 </searchLink><i>NLM ISO Abbreviation: </i>Protein Eng Des Sel <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25969511
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/protein/gzv025
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 231
    Titles:
      – TitleFull: Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gerlza T
      – PersonEntity:
          Name:
            NameFull: Winkler S
      – PersonEntity:
          Name:
            NameFull: Atlic A
      – PersonEntity:
          Name:
            NameFull: Zankl C
      – PersonEntity:
          Name:
            NameFull: Konya V
      – PersonEntity:
          Name:
            NameFull: Kitic N
      – PersonEntity:
          Name:
            NameFull: Strutzmann E
      – PersonEntity:
          Name:
            NameFull: Knebl K
      – PersonEntity:
          Name:
            NameFull: Adage T
      – PersonEntity:
          Name:
            NameFull: Heinemann A
      – PersonEntity:
          Name:
            NameFull: Weis R
      – PersonEntity:
          Name:
            NameFull: Kungl AJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2015 Aug
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1741-0134
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Protein engineering, design & selection : PEDS
              Type: main
ResultId 1